This presentation focuses on the challenges and opportunities in India’s healthcare system, accentuated by the COVID-19 pandemic. It emphasises the need for an overhaul in both the strategy and infrastructure of healthcare, including expanding and integrating primary, secondary, and tertiary care while leveraging India’s pharmaceutical strengths.